Zimmer Biomet Holdings ZBH
Valuation
Multiples measured against the stock's own five-year history
Around its usual level · 46th percentile, 5-year average 46.3x
#2039 of 2996 stocks by PE (1 = cheapest)
Below its usual level · 22nd percentile, 5-year average 1.8x
#2692 of 5338 stocks by PB (1 = cheapest)
Near the bottom of its 5-year range · 15th percentile, 5-year average 3.0x
#2830 of 5161 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 1.50 | – | 1.81 | 22% (cheaper than usual) | #2692 of 5338 (1 = cheapest) |
| PE | 25.53 | 19.61 | 46.27 | 46% (cheaper than usual) | #2039 of 2996 (1 = cheapest) |
| PS | 2.23 | 2.17 | 2.95 | 15% (cheaper than usual) | #2830 of 5161 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on ZBH.
Sign in to join the discussion.